Peficitinib (hydrobromide)
Peficitinib (ASP015K) hydrobromide is an orally active JAK inhibitor, with IC50s of 3.9, 5.0, 0.7 and 4.8 nM for JAK1, JAK2, JAK3 and Tyk2, respectively[1].
Product Specifications
CAS Number
1353219-05-2
Product Name Alternative
ASP015K (hydrobromide) ; JNJ-54781532 (hydrobromide)
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/peficitinib-hydrobromide.html
Solubility
10 mM in DMSO
Smiles
O[C@](C[C@@H]1C[C@H]2C3)(C2)C[C@@H]3[C@H]1NC4=C5C(NC=C5)=NC=C4C(N)=O.Br[H]
Molecular Formula
C18H23BrN4O2
Molecular Weight
407.30
References & Citations
[1]Ito M, et al. A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model. J Pharmacol Sci. 2017 Jan;133 (1) :25-33.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
JAK1; JAK2; JAK3; Tyk2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Survivin Antagonist, S12 (Survivin Inhibitor II, 3- (2- (benzo[d][1,3]dioxol-5-yl) -2-oxoethyl) -5-bromo-3-hydroxyindolin-2-one)](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
217816 10 mg
Survivin Antagonist, S12 (Survivin Inhibitor II, 3- (2- (benzo[d][1,3]dioxol-5-yl) -2-oxoethyl) -5-bromo-3-hydroxyindolin-2-one)
Sign In for Pricing
View Details 